Eversept Partners’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-71,596
Closed -$3.15M 73
2024
Q2
$3.15M Buy
+71,596
New +$3.15M 0.22% 52